RIV Capital buys New York cannabis chain Etain for US$247 million
Advertisement
Read this article for free:
or
Already have an account? Log in here »
To continue reading, please subscribe:
Digital Subscription
One year of digital access for only $205*
- Enjoy unlimited reading on winnipegfreepress.com
- Read the E-Edition, our digital replica newspaper
- Access News Break, our award-winning app
- Play interactive puzzles
*First annual payment billed as $205.00 + GST for one year. This annual subscription will automatically renew at $233.00 + GST every 52 weeks (10% off the regular annual price of $259.35). Offer available to new and qualified returning subscribers only. Cancel any time.
To continue reading, please subscribe:
Add Free Press access to your Brandon Sun subscription for only an additional
$1 for the first 4 weeks*
- Enjoy unlimited reading on winnipegfreepress.com
- Read the E-Edition, our digital replica newspaper
- Access News Break, our award-winning app
- Play interactive puzzles
*Your next Brandon Sun subscription payment will increase by $1.00 and you will be charged $17.95 plus GST for four weeks. After four weeks, your payment will increase to $24.95 plus GST every four weeks.
Read unlimited articles for free today:
or
Already have an account? Log in here »
Hey there, time traveller!
This article was published 30/03/2022 (1635 days ago), so information in it may no longer be current.
TORONTO – RIV Capital, Inc. says it will purchase medical marijuana retailer Etain in a US$247 million transaction.
The Toronto company previously known as Canopy Rivers says the deal to buy New York-based Etain will be comprised of US$212 million in cash and about US$35 million in Class A common shares in RIV Capital.
The deal is being financed in part by a subsidiary of Scotts Miracle-Gro and when it closes, Etain’s owners will hold about 16 per cent of its issued and outstanding Class A common shares.
RIV Capital says Etain is women-owned and -operated, one of the state’s original five medical cannabis licence recipients and has four operating dispensaries.
RIV Capital plans to invest additional capital and resources into four new Etain dispensaries, and to support the construction of a new flagship indoor cultivation facility that will target the premium market.
The deal is expected to close in the second quarter of 2022, but is subject to approvals.
RIV Capital, which was once the venture capital arm of Canopy Growth Corp., also announced Mark Sims will become its president and chief executive officer.
This report by The Canadian Press was first published March 30, 2022.